Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Paul Ausick | Apr 30, 2013 at 10:30 AM EDT

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock…

Jon C. Ogg | Apr 29, 2013 at 1:39 PM EDT

10 Key DJIA Events This Week: Earnings, Meetings, Dividend

This week should mark the climax of first quarter corporate earnings season. It will be a full week for the…

Jon C. Ogg | Apr 29, 2013 at 9:00 AM EDT

Merrill Lynch Lists Six Stocks Poised to Break Out

While the current stock market rally has been impressive since the lows last November, many investors, analysts and equity strategists…

Jon C. Ogg | Apr 25, 2013 at 8:15 AM EDT

Short Sellers Fight Top High-Yield Dividend Stocks

Jon OggShort sellers have increased their bets against some of the defensive high-yield dividend stocks, while paring down in others.…

Jon C. Ogg | Apr 11, 2013 at 8:20 AM EDT

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and…

Jon C. Ogg | Apr 10, 2013 at 8:00 AM EDT

Short Sellers Get Smarter About Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

Jon OggShort sellers may be getting smarter about all the inflows of capital heading into dividend stocks. The short interest fell in…

Jon C. Ogg | Apr 9, 2013 at 11:15 AM EDT

Our Earnings Poll: Which Rivals Will Do Better This Earnings Season? (AAPL, MSFT, JPM, WFC, MRK, PFE, T, VZ)

Jon Ogg24/7 Wall St. wants some insight from readers ahead of earnings season. We have grouped four rival sectors to see…

Jon C. Ogg | Mar 27, 2013 at 8:50 AM EDT

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MNKD, BAC)

ThinkstockAccording to the Center for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are…

Jon C. Ogg | Mar 27, 2013 at 7:05 AM EDT

Short Sellers Increase Their Bets Against Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

Jon OggShort sellers have kept their attack up against the high-dividend stocks, perhaps indicating that many investors believe that the…

Jon C. Ogg | Mar 12, 2013 at 10:25 AM EDT

Short Sellers Go to War Against Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

Jon OggShort sellers have continued to by and large increase their short-sale bets against the quality high-yield dividend stocks. The…

Paul Ausick | Mar 4, 2013 at 4:02 PM EST

24/7 Wall St. Closing Bell — March 4, 2013: Markets Open Lower, Rise at End of Day (YHOO, NS, GPS, DF, MRK, ARNA, BYD, SSYS, RIG, YGE, CKP, CEP, FOE, SCSS, SSYS)

U.S. equity markets opened lower this morning following news out of China that government is about to tighten restrictions on…

Jon C. Ogg | Mar 4, 2013 at 8:45 AM EST

Top Analyst Upgrades and Downgrades (AMAG, AON, BMY, SCHW, COH, BVN, DF, GPS, HGG, LXK, MRK, KORS, NS, RRGB, TIF, TJX, YHOO)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AMAG Pharmaceuticals…

Jon C. Ogg | Feb 28, 2013 at 10:05 AM EST

Short Sellers Raise Bets Against High-Yield Dividend Stocks (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Jon OggShort sellers have increased their bets by and large against our universe of go-to quality dividend stocks. We tracked…

Jon C. Ogg | Feb 12, 2013 at 1:36 PM EST

Short Sellers Maintain Assault Against High-Yield Dividend Stocks (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Jon OggShort sellers have had their challenges due to rising share prices since the start of 2013. They have gone…

Jon C. Ogg | Feb 8, 2013 at 10:10 AM EST

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited…

1 … 52 53 54 55 56 … 72

Merck : MRK

All Merck Articles

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

10 Key DJIA Events This Week: Earnings, Meetings, Dividend

Merrill Lynch Lists Six Stocks Poised to Break Out

Short Sellers Fight Top High-Yield Dividend Stocks

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

Short Sellers Get Smarter About Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

Our Earnings Poll: Which Rivals Will Do Better This Earnings Season? (AAPL, MSFT, JPM, WFC, MRK, PFE, T, VZ)

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MNKD, BAC)

Short Sellers Increase Their Bets Against Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

Short Sellers Go to War Against Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

24/7 Wall St. Closing Bell — March 4, 2013: Markets Open Lower, Rise at End of Day (YHOO, NS, GPS, DF, MRK, ARNA, BYD, SSYS, RIG, YGE, CKP, CEP, FOE, SCSS, SSYS)

Top Analyst Upgrades and Downgrades (AMAG, AON, BMY, SCHW, COH, BVN, DF, GPS, HGG, LXK, MRK, KORS, NS, RRGB, TIF, TJX, YHOO)

Short Sellers Raise Bets Against High-Yield Dividend Stocks (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Short Sellers Maintain Assault Against High-Yield Dividend Stocks (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Merck : MRK

All Merck Articles

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

10 Key DJIA Events This Week: Earnings, Meetings, Dividend

Merrill Lynch Lists Six Stocks Poised to Break Out

Short Sellers Fight Top High-Yield Dividend Stocks

Jefferies Gets Bullish on Pharma with Higher Targets (ABBV, ABT, BMY, PFE, ZTS, LLY, GSK, MRK, JEF)

Short Sellers Get Smarter About Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

Our Earnings Poll: Which Rivals Will Do Better This Earnings Season? (AAPL, MSFT, JPM, WFC, MRK, PFE, T, VZ)

Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MNKD, BAC)

Short Sellers Increase Their Bets Against Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

Short Sellers Go to War Against Top Dividend Stocks (MO, AEP, NLY, T, DUK, GE, KMB, KMP, MRK, PG, RAI, VZ)

24/7 Wall St. Closing Bell — March 4, 2013: Markets Open Lower, Rise at End of Day (YHOO, NS, GPS, DF, MRK, ARNA, BYD, SSYS, RIG, YGE, CKP, CEP, FOE, SCSS, SSYS)

Top Analyst Upgrades and Downgrades (AMAG, AON, BMY, SCHW, COH, BVN, DF, GPS, HGG, LXK, MRK, KORS, NS, RRGB, TIF, TJX, YHOO)

Short Sellers Raise Bets Against High-Yield Dividend Stocks (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

Short Sellers Maintain Assault Against High-Yield Dividend Stocks (MO, AEP, NLY, T, DUK, KMB, KMP, MRK, PG, RAI, VZ)

﻿﻿JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)